These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7629877)

  • 61. Bone morphogenetic proteins in melanoma: angel or devil?
    Hsu MY; Rovinsky S; Penmatcha S; Herlyn M; Muirhead D
    Cancer Metastasis Rev; 2005 Jun; 24(2):251-63. PubMed ID: 15986135
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of tumor cell evolution in a melanoma: evidence of mutational and selective pressure for loss of p16ink4 and for microsatellite instability.
    Rübben A; Babilas P; Baron JM; Hofheinz A; Neis M; Sels F; Sporkert M
    J Invest Dermatol; 2000 Jan; 114(1):14-20. PubMed ID: 10620109
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic factors in melanoma outcome and survival.
    Le TT; Pitman KT
    Facial Plast Surg Clin North Am; 2003 Feb; 11(1):33-41. PubMed ID: 15062285
    [No Abstract]   [Full Text] [Related]  

  • 64. Variation and progress.
    Nevin JA
    J Exp Anal Behav; 1987 Nov; 48(3):489-90. PubMed ID: 16812524
    [No Abstract]   [Full Text] [Related]  

  • 65. Natural course of untreated cutaneous melanoma.
    Ahlgrimm-Siess V; Massone C; Hofmann-Wellenhof R; Kerl H
    Dermatol Surg; 2008 Mar; 34(3):371-3. PubMed ID: 18177394
    [No Abstract]   [Full Text] [Related]  

  • 66. Objective melanoma progression.
    Rubegni P; Burroni M; Nami N; Cevenini G; Bono R; Sbano P; Fimiani M
    Skin Res Technol; 2011 Feb; 17(1):69-74. PubMed ID: 20923468
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Function association of tissue inhibitor of metalloproteinase-1 and malignant melanoma: systomics approach.
    Wiwanitkit V
    Acta Dermatovenerol Croat; 2010; 18(1):68. PubMed ID: 20361890
    [No Abstract]   [Full Text] [Related]  

  • 68. Seasonal variation in melanoma progress.
    Akslen LA
    J Natl Cancer Inst; 1995 Jul; 87(13):1025-6. PubMed ID: 7629877
    [No Abstract]   [Full Text] [Related]  

  • 69. Integrins and melanoma progression.
    Danen EH; van Muijen GN; ten Berge PJ; Ruiter DJ
    Recent Results Cancer Res; 1993; 128():119-32. PubMed ID: 8356314
    [No Abstract]   [Full Text] [Related]  

  • 70. Genetic progression of metastatic melanoma.
    Rodolfo M; Daniotti M; Vallacchi V
    Cancer Lett; 2004 Oct; 214(2):133-47. PubMed ID: 15363539
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Wnt-er wonderland--the complexity of Wnt signaling in melanoma.
    Weeraratna AT
    Cancer Metastasis Rev; 2005 Jun; 24(2):237-50. PubMed ID: 15986134
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.